ClinConnect ClinConnect Logo
Search / Trial NCT06899347

The Role of Prophylactic Central Compartment Neck Dissection in the Management of 2 to 4 Cm Papillary Thyroid Carcinoma

Launched by LEONARDO ROSSI · Mar 20, 2025

Trial Information

Current as of April 22, 2025

Not yet recruiting

Keywords

Papillary Thyroid Carcinoma Prophylactic Central Compartment Neck Dissection Thyroidectomy Surgical Complications Outcomes

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. PTC documented by fine needle aspiration cytology (FNAC) (TIR 4 or TIR 5 according to the Italian consensus for the classification and reporting of thyroid cytology \[15\]);
  • 2. no pre-operative evidence of lymph node metastases (cN0) at palpation and neck ultrasound (US);
  • 3. no clinical evidence of distant metastasis at diagnosis;
  • 4. age ≥ 18 years.
  • Exclusion Criteria:
  • 1. histotypes other than PTC;
  • 2. evidence of lymph node metastases during surgery even if not previously diagnosed;
  • 3. presence of distant metastasis.

About Leonardo Rossi

Leonardo Rossi is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on rigorous scientific methodology and ethical standards, Mr. Rossi oversees clinical studies that span various therapeutic areas, ensuring robust data collection and analysis. His extensive experience in clinical operations and strategic planning enables the successful execution of trials, fostering collaboration with healthcare professionals and regulatory bodies. Through a patient-centered approach, Leonardo Rossi aims to contribute significantly to the development of safe and effective treatments that address unmet medical needs.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported